Journal of Autism and Developmental Disorders

, Volume 35, Issue 4, pp 515–518

The Treatment of the Behavioral Sequelae of Autism with Dextromethorphan: A Case Report

  • Cooper Woodard
  • June Groden
  • Matthew Goodwin
  • Cori Shanower
  • Joanne Bianco
Article

Abstract

Dextromethorphan is the d-isomer of levorphenol, and an ingredient in antitussive preparations. A 10 year-old male diagnosed with Autistic Disorder, Pervasive Developmental Disorder, and Generalized Anxiety Disorder was administered this medication initially to treat a medical condition. This became a quasi-experimental ABAB design (A = baseline, B = treatment), with improvements during treatment phases shown in tracked behavioral data and anecdotal reports. Several candidate mechanisms to explain the improvements are offered, including glutamate receptor antagonism. While dextromethorphan is not commonly administered for the treatment of behavioral challenges in this or any population, the results suggest the need for larger-scale, adequately controlled, and methodologically rigorous studies of the potential clinical effects of dextromethorphan.

Keywords

Autism dextromethorphan glutamate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Carlsson, M. L. 1998Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate— serotonin interactions for pharacotherapyJournal of Neural Transmission105525535CrossRefPubMedGoogle Scholar
  2. McDougle, C. J. (2002). Current and Emerging Therapeutics of Autistic Disorder and Related Pervasive Developmental Disorders.In K. L. Davis, D. Charney, J. T. Coyle, & C Nemeroff(Eds.), .(pp. 566–577). Philadelphia: Lippincott Williams andWilkins.Google Scholar
  3. Phillips, J. A., Hamid, R., & McGrew, S. (1999, October). Effects of dextromethorphan in autistic children with abnormal amino acid profiles. Program 2861 presented at the annual meeting of the American Society of Human Genetics (ASHG), San Francisco, CAGoogle Scholar
  4. Welch, L., Sovner, R. 1992The treatment of a chronic organic mental disorder with dextromethorphan in a man with severe mental retardationBritish Journal of Psychiatry161118120PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Cooper Woodard
    • 1
  • June Groden
    • 1
  • Matthew Goodwin
    • 1
  • Cori Shanower
    • 1
  • Joanne Bianco
    • 1
  1. 1.The Groden CenterProvidenceUSA

Personalised recommendations